En savoir plus
Lipid nanocarriers are a novel drug delivery system that utilizes tiny, fat-based particles to target and treat cancer cells. These nanocarriers have shown great promise in: Targeted delivery: Directly delivering anticancer drugs to tumor sites, reducing side effects, and improving efficacy. Improved bioavailability: Enhancing the absorption and distribution of drugs, leading to better therapeutic outcomes.Enhanced therapeutic index: Maximizing the therapeutic effect while minimizing toxicity.Combination therapy: Allowing for the co-delivery of multiple drugs, targeting various aspects of cancer biology. The benefits of lipid nanocarriers include:Biocompatibility: Composed of natural lipids, reducing toxicity and immunogenicity. Flexibility: Can be engineered to deliver a wide range of anticancer agents.Scalability: Can be produced on a large scale, making them a viable option for clinical translation. Overall, lipid nanocarriers offer a promising approach for cancer treatment, providing a targeted, efficient, and safe way to deliver anticancer therapies.
A propos de l'auteur
Dr.R.Devi has 14 Years of teaching experience. She published more than 33 Books and 32 book Chapters.Dr.Daisy Chella Kumari is working as an Assistant Professor at the College of Pharmacy, Madras Medical College.She has 25 years of Teaching experience.Ms.Varalakshmi as a Scholar of FOP, Bharath Institute of Higher Education and Research,Chennai.
